Virtual Reality for Generalized Anxiety Disorders

Clinical Research Centre, Malaysia80 enrolled

Overview

The goal of this clinical trial is to apply Virtual Reality as an adjunct treatment for Generalized Anxiety Disorder. The main question it aims to answer are: * Determination of the efficacy of VR modules as an adjunct therapy in improving GAD-7 scores * Assessment of the acceptability of VR modules as an adjunct therapy to the standard of care Participants will randomized into two arms: * Control Arm: Standard of Care only * Intervention Arm: Standard of Care + VR Modules

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

Conditions

Generalized Anxiety Disorder

Interventions

Virtual RealityOTHER

Virtual Reality as adjunct treatment

Eligibility

Sex: ALLMin age: 18 YearsMax age: 59 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Age between 18-59 2. The primary diagnosis is a generalized anxiety disorder 3. Agree to participate and consented as per study protocol. 4. There is no change in the standard of care within the past two months prior to enrollment into the study. If a patient is on any psychotherapy, then there is no change in the type of current psychotherapy intervention. 5. GAD- 7 more than or equal to 5. 6. Able to come for the session as per scheduled. Exclusion Criteria: 1. Documented or known case of permanent hearing/visual impairment e.g., vestibular abnormalities that represent significant contraindications for the use of VR or visual impairment e.g., cataract. 2. Documented Disorder as listed: * A. Psychosis * B. Psychosis disorder - previous case, known case of * C. Claustrophobia * D. Substance use * E. Personality disorder * F. Visual impairment that might hinder usage of virtual reality equipment * G. Intellectual disabilities * H. All types of seizures including febrile seizure 3. The patient is under more than 1 center during follow up (e.g., patient is also receiving treatment from a private hospital for GAD).

Locations (5)

Hospital Sultanah Aminah

Johor Bahru, Johor, Malaysia

Hospital Permai

Johor Bahru, Johor, Malaysia

Hospital Sultanah Bahiyah

Alor Star, Kedah, Malaysia

Hospital Kulim

Kulim, Kedah, Malaysia

Outcomes

Primary Outcomes

To determine the efficacy of VR modules as an adjunct therapy in improving GAD-7 scores among patients with generalized anxiety disorders.

Patient will be access with GAD-7 questionnaire repeatedly at different time interval (3 Times - Week 0, Week 2, Week 4) .

Time frame: Week 0 - Week 4

Secondary Outcomes

To assess the acceptability of VR modules as an adjunct therapy to the standard of care among patients with generalized anxiety disorders.

Patient will assess with standard questionnaire on acceptability of VR technology (3 Times - Week 0, Week 2, Week 4).

Time frame: Week 0 - Week 4

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.